-
Product Insights
Neoplastic Syndrome Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Neoplastic Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Neoplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Neoplastic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Mycosis Fungoides Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H2, 2016" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Subependymal Giant Cell Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials on Subependymal Giant Cell Astrocytoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral T-Cell Lymphomas (PTCL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC): Dynamic Market Forecast to 2025
The NSCLC therapeutics market is a rapidly evolving field in which new developments are constantly influencing the landscape. The Forecast Update is designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand how these events will impact the market forecast.
-
Product Insights
Hematological Tumor Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2017" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Hematological Tumor. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hepatocellular Carcinoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H2, 2017" provides an overview of Hepatocellular Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatocellular Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
High-Grade Glioma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H2, 2017" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...